News
Watch
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Morgan Alvah, PharmD

Articles by Morgan Alvah, PharmD

Subcutaneous injection -- Image credit: PhotobyTawat | stock.adobe.com

Pharmacy Department-Driven Initiative to Reduce Subcutaneous Daratumumab Observation Time

ByMonica Tadros, PharmD, BCPS, BCOP,Tiba Al Sagheer, PharmD, BCOP, BCACP,Morgan Alvah, PharmD

June 18th 2024

Peer Reviewed

Observation time on subsequent injections of subcutaneous daratumumab may be safely removed from institutional policies to reduce chair time.

Latest Updated Articles

Trending on Pharmacy Times

Overcoming Barriers to Kidney-Protective Therapy

Night Shift Work, Chronic Insomnia Nearly Triple Long-COVID Risk, Study Finds

8 PDUFA Dates to Watch in Fall and Winter 2026

Biosimilars: A Guide for Pharmacists

FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma